Uncategorized
Aerie to manufacture Rhopressa, Roclatan in Ireland
Aerie Pharmaceuticals plans to commercially produce its product candidates Rhopressa and Roclatan in Ireland following the signing of a lease agreement with Ireland’s Industrial Development Agency, the company announced in a press release.Aerie will begin work on the interior of the already built 30,000-square-foot building shell in Athlone, Ireland, immediately. The project is expected to cost about $25 million, the release said.